School of Medicine
Daniel T. Kincaid is in his 50th year of practicing cardiology and critical care full time (including call) with the Mayo Clinic Health System in Eau Claire, Wisconsin.
Steven A. Wartman, internist and sociologist of Lexington, Massachusetts, is president-elect of the Alpha Omega Alpha Medical Honor Society. Since 2005, he has served as the third president and CEO of the Association of Academic Health Centers (AAHC) in Washington, D.C. In 2008, he founded AAHC International, a global organization dedicated to improving health and well-being worldwide.
Kenneth M. Ludmerer has received the 2022 John C. Gienapp Award for Distinguished Service to Graduate Medical Education from the Accreditation Council for Graduate Medical Education (ACGME). He is being recognized for his role in chronicling the residency experience in his book Let Me Heal, for amplifying the role of clinician well-being, and for his vital role in the development of the current ACGME Common Program Requirements, which owe very much to concepts advanced in Let Me Heal.
Robert M. Ward, who joined the University of Utah Division of Neonatology in 1985 and established the Division of Clinical Pharmacology in 1995, was recently honored by the University of Utah with the establishment of the Robert M. Ward, M.D., Endowed Chair in Clinical Pharmacology in the Department of Pediatrics. Ward served on the Pediatric Advisory Committee of the Food and Drug Administration for 10 years and as principal investigator for the Utah Pediatric Pharmacology Research Unit of the National Institute of Child Health and Development. He collaborated in the development of federal legislation to increase the study of drugs in children while chair of the American Academy of Pediatrics Committee on Drugs. These laws were made permanent in 2012.
L. Michael Brunt, professor of surgery and section chief of minimally invasive surgery at the Washington University School of Medicine in St. Louis, is president of the Fellowship Council, which oversees more than 170 postgraduate gastrointestinal surgical fellowship programs, and immediate past president of the Central Surgical Association.
Donald C. Manning, of Morris Plains, New Jersey, has been named chief medical officer and head of R&D at Travecta Therapeutics. He has more than 25 years of experience in drug development and has held management positions in a range of pharmaceutical companies, including Novartis, Celgene, Alpharma, Shionogi and Adynxx.
David P. Carbone, of Hilliard, Ohio, was named the 2021 recipient of the Bunn Scientific Award by the International Association for the Study of Lung Cancer. He is a professor of internal medicine and director of the James Thoracic Oncology Center at The Ohio State University Comprehensive Cancer Center and Solove Research Institute. His recent research has focused on the development of molecular biomarkers to guide patient treatment and molecular profiling of lung cancers and preneoplasias to guide the development of novel therapeutics, especially using mass spectrometry–based proteomics.
Daniel J. McGraw, a vascular surgeon who recently retired from practicing in Parkersburg, West Virginia, and has since moved to New Braunels, Texas, received the Society for Vascular Surgery’s Excellence in Community Service Award for 2021. He is an expert in carotid endarterectomy, aortic aneurysm, and peripheral vascular disease.
Helen L. Collins, of Santa Rosa, California, has been appointed to the board of directors of Kura Oncology, a clinical-stage biopharmaceutical company focused on precision medicines for the treatment of cancer. Collins most recently served as executive vice president and chief medical officer at Five Prime Therapeutics, where she was responsible for the strategy and execution of the company’s clinical development plans until its acquisition by Amgen in April 2021.
Douglas P. Clark, of Santa Fe, New Mexico, was appointed chief medical officer at Ibex Medical Analytics in September 2021. Tel Aviv, Israel–based Ibex uses AI and machine learning technology to power its platform for cancer diagnostics. Clark previously served as CMO at TriCore and has worked as a physician, professor of pathology and senior executive throughout his career. He chaired the pathology department at the University of New Mexico School of Medicine and was a professor of pathology and oncology at The Johns Hopkins Medical Institutions.
Hyung Tai Kim, internist and physician executive of Grand Rapids, Michigan, has been named CEO of LifeFlow Partners, a physician-owned, private-equity-backed endovascular practice partnership, which will enable physicians to improve the operational and economic performance of their practices to advance patient care and to maximize value.
Lawrence Kim, of Littleton, Colorado, has been elected secretary/treasurer of the Accreditation Association for Ambulatory Health Care (AAAHC). The first gastroenterologist to join the AAAHC board of directors, Kim is a partner at South Denver Gastroenterology, a 24-physician independent gastroenterology practice in Colorado.
Tamara Elias, of Larchmont, New York, earlier this year joined the board of BehaVR Inc., which offers virtual-reality-based digital wellness and digital therapeutic experiences. She serves as vice president and head of Global Partnerships and Innovation at Merck.
Siddhartha C. Kadia, of Solana Beach, California, has joined the board of Berkeley Lights Inc. as an independent director. Berkeley Lights is a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics.
Lefei Sun, of Hong Kong, managing director and head of healthcare for China at General Atlantic, has joined the board of Genesis Medtech International, a medical device company financed by General Atlantic. “We are excited to help propel the work that Genesis is doing to advance access to healthcare and innovative medical solutions in emerging markets,” he said. Before joining General Atlantic in 2018, Sun was the founding partner of Huatai Healthcare Investment Fund, OrbiMed, Orchid Asia and McKinsey.
Xin Huang, of Beijing, China, was named to the board of directors of NeuExcell Therapeutics in August 2021 in conjunction with a series A funding round co-led by Co-Win Ventures, of which he is managing partner.
Blake Aftab, of Thousand Oaks, California, has been promoted to chief scientific officer at Adicet Bio Inc., a biotechnology company working to discover and develop allogeneic gamma delta T cell therapies for cancer and other diseases.
former faculty fellows and house staff
Barry S. Verkauf (HS, obstetrics, 1966–1972), of Tampa, Florida, has retired from the practice of medicine. He started both the Menopause Center and the Division of Reproductive Endocrinology and Infertility at University of South Florida’s Morsani College of Medicine in Tampa. He was involved with the first in vitro fertilization birth in Florida.
Stanford M. Goldman (faculty, radiology, 1971–1993), of Houston, Texas, former chair of Department of Radiology at Johns Hopkins Bayview Medical Center, has completely retired from the McGovern School of Medicine of the University of Texas, Houston, where he was professor emeritus of radiology, professor of urology and former chairman from 1993 to 2001.
Randolph M. Howes (HS, surgery, 1971–1977; fellow, plastic surgery, 1975–1977), of Kentwood, Louisiana, invented and patented the Triple Lumen Venous Catheter in 1978 (patent number 4,072,146). According to Arrow International Inc., Howes’ catheter went on to become the number one venous catheter in the world.
Ahmed A. Saada (fellow, otolaryngology, 1992–1997) has been appointed chair of the Department of Otolaryngology at the Alexandria University Students’ Hospital in Alexandria, Egypt.
Gail L. Daumit (HS, internal medicine, 1996–1999; current faculty, internal medicine and psychiatry and behavioral sciences), of Baltimore, Maryland, has been named vice dean for clinical investigation at the Johns Hopkins University School of Medicine. During her career at Hopkins, she has served as the associate director of the Welch Center for Prevention, Epidemiology and Clinical Research as well as the research director of the Division of General Internal Medicine in the Department of Medicine. Her research has focused on developing innovative ways to improve the physical health of people with mental illness through descriptive epidemiology, health services research, clinical trials, and implementation science. As vice dean, she will be the designated institutional official for oversight of the human subjects research program.